nicorandil has been researched along with Hyperglycemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, P; Cheng, JT; Liu, IM; Tzeng, TF; Wong, KL; Yang, TL | 1 |
| Amano, T; Ichimiya, S; Ishii, H; Kanashiro, M; Matsubara, T; Murohara, T | 1 |
1 trial(s) available for nicorandil and Hyperglycemia
| Article | Year |
|---|---|
Effects of intravenous nicorandil before reperfusion for acute myocardial infarction in patients with stress hyperglycemia.
Topics: Aged; Angioplasty, Balloon, Coronary; Blood Glucose; Cardiotonic Agents; Combined Modality Therapy; Coronary Angiography; Creatine Kinase; Diabetes Complications; Disease-Free Survival; Electrocardiography; Female; Follow-Up Studies; Humans; Hyperglycemia; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Nicorandil; Proportional Hazards Models; Prospective Studies | 2006 |
1 other study(ies) available for nicorandil and Hyperglycemia
| Article | Year |
|---|---|
Antihyperglycemic action of angiotensin II receptor antagonist, valsartan, in streptozotocin-induced diabetic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Glucose; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Gene Expression; Glucose Tolerance Test; Glucose Transporter Type 4; Hyperglycemia; Liver; Male; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Nicorandil; Nifedipine; Phosphoenolpyruvate Carboxykinase (GTP); Rats; Rats, Wistar; RNA, Messenger; Saralasin; Tetrazoles; Valine; Valsartan | 2003 |